Sara van den Berg

109 4 CMV on influenza infection 40. McElhaney, J.E., et al., Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine, 2009. 27(18): p. 2418-25. 41. McElhaney, J.E., et al., T-cell responses are better correlates of vaccine protection in the elderly. J Immunol, 2006. 176(10): p. 6333-9. 42. Rosendahl Huber, S.K., et al., Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity. Front Immunol, 2018. 9: p. 3103. 43. Pel, J.Z.S., Proefonderzoek naar de frequentie en de aetiologie van griepachtige ziekten in de winter 1963-1964. Huisarts en Wetenschap 1965. 86: p. 321. 44. van Beek, J., et al., Influenza-like Illness Incidence Is Not Reduced by Influenza Vaccination in a Cohort of Older Adults, Despite Effectively Reducing Laboratory-Confirmed Influenza Virus Infections. J Infect Dis, 2017. 216(4): p. 415-424. 45. Tcherniaeva, I., et al., The development of a bead-based multiplex immunoassay for the detection of IgG antibodies to CMV and EBV. J Immunol Methods, 2018. 462: p. 1-8. 46. Kotecha, N., P.O. Krutzik, and J.M. Irish, Web-based analysis and publication of flow cytometry experiments. Curr Protoc Cytom, 2010. Chapter 10: p. Unit10 17. 47. Derhovanessian, E., et al., Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans. J Gen Virol, 2011. 92(Pt 12): p. 2746-56. 48. Skowronski, D.M., et al., Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. J Infect Dis, 2011. 203(2): p. 158-67. 49. Wertheimer, A.M., et al., Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T-cell subsets in humans. J Immunol, 2014. 192(5): p. 2143-55. 50. Deng, Y., et al., Age-related impaired type 1 T-cell responses to influenza: reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol, 2004. 172(6): p. 3437-46. 51. Nguyen, T.H.O., et al., Perturbed CD8+ T-cell immunity across universal influenza epitopes in the elderly. J Leukoc Biol, 2017. 52. Murasko, D.M.B., E.D. Gardner, E.M. Gross, P. Munk, G. Dran, S. Abrutyn, E. , Role of humoral and cell-mediated immunity in protection from in¯uenza disease after immunization of healthy elderly. Experimental Gerontology, 2002. 37: p. 427-439. 53. Derhovanessian, E., et al., Latent infection with cytomegalovirus is associated with poor memory CD4 responses to influenza A core proteins in the elderly. J Immunol, 2014. 193(7): p. 3624-31. 54. Merani, S., et al., Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection. Front Immunol, 2017. 8: p. 784. 55. Theeten, H., et al., Cellular Interferon Gamma and Granzyme B Responses to Cytomegalovirus-pp65 and Influenza N1 Are Positively Associated in Elderly. Viral Immunol, 2016. 29(3): p. 169-75. 56. Smithey, M.J., et al., Lifelong CMV infection improves immune defense in old mice by broadening the mobilized TCR repertoire against third-party infection. Proc Natl Acad Sci U S A, 2018. 115(29): p. E6817-E6825. 57. Tavenier, J., J.B. Margolick, and S.X. Leng, T-cell immunity against cytomegalovirus in HIV infection and aging: relationships with inflammation, immune activation, and frailty. Med Microbiol Immunol, 2019. 208(3-4): p. 289-294. 58. Redeker, A., et al., The Contribution of Cytomegalovirus Infection to Immune Senescence Is Set by the Infectious Dose. Front Immunol, 2017. 8: p. 1953.